Overall, our findings reveal that DNA methyltransferases (DNMT1 and DNMT3A) mediate the hypermethylation of the CBX7 promoter, leading to its frequent downregulation in glioblastoma tissues and cell lines. Here, DNMT3A is linked to glioblastoma.